Perception du risque tératogène des médicaments chez la femme enceinte

Simple item page
dc.contributor.advisorM. M. Zguhdi
dc.contributor.authorGhizlane Bentaleb
dc.date.accessioned2023-09-15T13:37:52Z
dc.date.accessioned2026-01-22T13:32:05Z
dc.date.available2023-09-15T13:37:52Z
dc.date.issued2011
dc.description.collaboratorO. Chokairi
dc.description.collaboratorB. Rhrab
dc.description.collaboratorH. Ait Guamar
dc.identifier.urihttps://toubkal.imist.ma/handle/123456789/18644
dc.identifier.urihttps://doi.org/10.83129/toubkal-7645
dc.language.isofr
dc.publisherUniversité Mohammed 5 de Rabat, Faculté de Médecine et de Pharmacie, Rabatfr_FR
dc.subjectTeratogenesefr_FR
dc.subjectPhamacovigilancefr_FR
dc.subjectEmbypathiesfr_FR
dc.subjectFcetopathiesfr_FR
dc.subjectGrossessefr_FR
dc.subject.otherSciences médicales
dc.subject.specificPharmacology
dc.titlePerception du risque tératogène des médicaments chez la femme enceintefr_FR

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
P0502011.pdf
Size:
2.27 MB
Format:
Adobe Portable Document Format
Download

Collections

Faculté de Médecine et de Pharmacie - Rabat